Singapore markets open in 5 hours 58 minutes

A Jan 2023 165.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
2.00000.0000 (0.00%)
As of 03:29PM EDT. Market open.
Full screen
Previous close2.0000
Open1.8000
Bid2.2000
Ask3.7000
Strike165.00
Expiry date2023-01-20
Day's range1.8000 - 2.0000
Contract rangeN/A
Volume3
Open interest609
  • Business Wire

    Agilent Announces Cash Dividend of 21 Cents per Share

    SANTA CLARA, Calif., May 18, 2022--Agilent Technologies Inc. (NYSE: A) today announced a quarterly dividend of 21 cents per share of common stock will be paid on July 27, 2022, to all shareholders of record as of the close of business on July 5, 2022.

  • Zacks

    Agilent Technologies (A) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

    Agilent (A) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Business Wire

    Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Cervical Cancer

    SANTA CLARA, Calif., May 10, 2022--Agilent Technologies Inc. (NYSE: A) today announced that its PD-L1 IHC 22C3 pharmDx, Code SK006, is now EU CE-IVD–marked for use in cervical cancer. PD-L1 IHC 22C3 pharmDx can be used as an aid in identifying cervical cancer patients for whom treatment with KEYTRUDA® (pembrolizumab) may be appropriate.1 KEYTRUDA is an anti-PD-1 therapy developed by Merck (known as MSD outside the U.S. and Canada). In Europe, KEYTRUDA, in combination with chemotherapy with or wi